Amir Behdad

3.0k total citations
93 papers, 1.3k citations indexed

About

Amir Behdad is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Amir Behdad has authored 93 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 45 papers in Cancer Research and 39 papers in Pathology and Forensic Medicine. Recurrent topics in Amir Behdad's work include Cancer Genomics and Diagnostics (41 papers), Lymphoma Diagnosis and Treatment (25 papers) and Cancer Cells and Metastasis (17 papers). Amir Behdad is often cited by papers focused on Cancer Genomics and Diagnostics (41 papers), Lymphoma Diagnosis and Treatment (25 papers) and Cancer Cells and Metastasis (17 papers). Amir Behdad collaborates with scholars based in United States, Italy and Ukraine. Amir Behdad's co-authors include Massimo Cristofanilli, William J. Gradishar, Leonidas C. Platanias, Firas Wehbe, Lorenzo Gerratana, Ami N. Shah, Arie Perry, Andrew A. Davis, Barbara Pro and Pamela B. Allen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Amir Behdad

87 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amir Behdad United States	22	543	451	316	303	292	93	1.3k
Natacha Entz‐Werlé France	19	428 0.8×	426 0.9×	588 1.9×	399 1.3×	441 1.5×	83	1.5k
Laura Morsberger United States	16	470 0.9×	433 1.0×	569 1.8×	123 0.4×	339 1.2×	43	1.3k
Michaela Nathrath Germany	24	647 1.2×	392 0.9×	689 2.2×	313 1.0×	591 2.0×	70	1.8k
Barbara Bernasconi Italy	21	418 0.8×	192 0.4×	441 1.4×	251 0.8×	148 0.5×	47	1.1k
Matthias S. Dettmer Switzerland	21	552 1.0×	263 0.6×	504 1.6×	105 0.3×	146 0.5×	65	1.6k
Boryana Zhelyazkova United States	3	332 0.6×	443 1.0×	506 1.6×	162 0.5×	357 1.2×	4	1.2k
Andréï Tchirkov France	22	389 0.7×	412 0.9×	702 2.2×	174 0.6×	173 0.6×	88	1.7k
Aniello Cerrato Italy	24	668 1.2×	325 0.7×	957 3.0×	121 0.4×	240 0.8×	33	1.7k
Charles D. Bangs United States	19	580 1.1×	145 0.3×	605 1.9×	247 0.8×	264 0.9×	44	1.6k
Julien Masliah‐Planchon France	18	244 0.4×	348 0.8×	957 3.0×	340 1.1×	263 0.9×	78	1.6k

Countries citing papers authored by Amir Behdad

Since Specialization

Citations

This map shows the geographic impact of Amir Behdad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Behdad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Behdad more than expected).

Fields of papers citing papers by Amir Behdad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Behdad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Behdad. The network helps show where Amir Behdad may publish in the future.

Co-authorship network of co-authors of Amir Behdad

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Behdad. A scholar is included among the top collaborators of Amir Behdad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Behdad. Amir Behdad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, Andrew A., Ian S. Hagemann, Amir Behdad, et al.. (2025). Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity. Clinical Cancer Research. 31(21). 4485–4494.

Murga‐Zamalloa, Carlos, Ankit I. Mehta, Irum Khan, et al.. (2024). Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population. American Journal of Clinical Pathology. 161(6). 586–597. 1 indexed citations

Gerratana, Lorenzo, Andrew A. Davis, Carolina Reduzzi, et al.. (2023). Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis. JCO Precision Oncology. 7(7). e2200531–e2200531. 7 indexed citations

Nicolò, Eleonora, Elena Vagia, Paolo D’Amico, et al.. (2023). Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion. JCO Precision Oncology. 7(7). e2200702–e2200702. 2 indexed citations

Gerratana, Lorenzo, Katherine Clifton, Arielle J. Medford, et al.. (2023). Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer. Clinical Cancer Research. 29(16). 3092–3100. 4 indexed citations

Gerratana, Lorenzo, Andrew A. Davis, Katherine Clifton, et al.. (2023). Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis. Breast Cancer Research. 25(1). 112–112. 7 indexed citations

Segal, Jeremy, Sandeep Gurbuxani, Irene Helenowski, et al.. (2022). Therapy‐related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype. British Journal of Haematology. 197(6). 736–744. 8 indexed citations

Lin, Adam Yuh, Bongseo Choi, Taehoon Sim, et al.. (2022). Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide–coated nanoparticles. Blood Advances. 6(15). 4581–4592. 6 indexed citations

Sukhanova, Madina, Amir Behdad, Lawrence J. Jennings, et al.. (2022). Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features. Human Pathology. 129. 81–89. 1 indexed citations

10.

Jacob, Saya, Andrew A. Davis, Lorenzo Gerratana, et al.. (2021). The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer. Clinical Cancer Research. 27(5). 1361–1370. 35 indexed citations

11.

Liu, Xiaoran, Andrew A. Davis, Feng Xie, et al.. (2021). Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China. Breast Cancer Research and Treatment. 190(2). 213–226. 5 indexed citations

12.

Rink, Jonathan S., Adam Yuh Lin, Kaylin M. McMahon, et al.. (2020). Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. Journal of Biological Chemistry. 296. 100100–100100. 42 indexed citations

13.

Oh, Michael S., Derek A. Wainwright, Nisha Mohindra, et al.. (2020). The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Clinical Lung Cancer. 22(1). e57–e62. 57 indexed citations

14.

Gerratana, Lorenzo, Andrew A. Davis, Maurizio Polano, et al.. (2020). Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools. European Journal of Cancer. 143. 147–157. 36 indexed citations

15.

Zhang, Yanming, Alain Mina, Jessica K. Altman, et al.. (2019). An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: a single institution experience. Human Pathology. 91. 1–10. 5 indexed citations

16.

Davis, Andrew A., Qiang Zhang, Lorenzo Gerratana, et al.. (2019). Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer. Breast Cancer Research. 21(1). 137–137. 42 indexed citations

17.

Choi, Sarah M., Aleodor A. Andea, Min Wang, et al.. (2018). KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma. Diagnostic Pathology. 13(1). 78–78. 8 indexed citations

18.

Rossi, Giovanna, Zhaomei Mu, Alfred Rademaker, et al.. (2017). Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer. Clinical Cancer Research. 24(3). 560–568. 106 indexed citations

19.

Choi, Sarah M., Benjamin Goldenson, Lo Ann C. Peterson, et al.. (2017). Diagnostic and therapeutic implications of genetic heterogeneity in myeloid neoplasms uncovered by comprehensive mutational analysis. Leukemia Research Reports. 8. 11–13. 1 indexed citations

20.

Behdad, Amir & Arie Perry. (2009). Central Nervous System Primitive Neuroectodermal Tumors: A Clinicopathologic and Genetic Study of 33 Cases. Brain Pathology. 20(2). 441–450. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact